Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation Using Standard-Dose Post-Transplantation Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis: Insights from the NMDP-Sponsored, CIBMTR-Led ACCESS Trial

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Jeffery James Auletta, Joseph R. Stanek, Stephanie Bo‐Subait, Monzr M. Al Malki, Rachel Cook, Mahasweta Gooptu, Brian C. Shaffer, Antonio Jimenez Jimenez, Dipenkumar Modi, Heather Emily Stefanski, Larisa A. Broglie, Bronwen E. Shaw
+2 more Stephen R. Spellman, Steven Michael Devine
DOI: 10.1016/j.jtct.2025.12.136
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Neutropenia and Cancer Infections Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S93–S93
Publication date
1 February 2026
Language
EN